Lannett Company, Inc. (NYSEMKT:LCI)
CAPS Rating:
The Company develops, manufactures, markets and distributes generic versions of pharmaceutical products.
Investment advice you can actually understand
The Company develops, manufactures, markets and distributes generic versions of pharmaceutical products.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Whoever said this stock is under valued needs to learn what value really is. LCI has a PE ratio over 100. The stock trades within 10% of its 52 week high. Returns on assets, equity, and capital is almost nothing. No dividend. Less than 2% profit margin is weak. This is not value.
I want to see this stock drop down to $3 per share before I close this out.